Micah Benson

Company: KSQ Therapeautics

Job title: Chief Scientific Officer

Seminars:

Rational Design of CRISPR/Cas9-engineered TIL Therapies 11:30 am

• Harnessing CRISPR to identify TIL-enhancing targets • Analyzing designing and manufacturing next-gen TIL therapies with increased anti-tumor potency • Examining KSQ-001 and KSQ-004 as single- and dual-edited CRISPR/Cas9- engineered TIL productsRead more

day: Day Two